Our latest trend analysis of the Swiss biotechnology and life sciences sector shows that despite a slow start to the year, investment in the area rose substantially in the second half of 2015. However the decline in the amount of new biotech companies being founded has continued. In fact last year had the lowest number of … Continue reading Swiss Life Sciences Trend Analysis 2016
Year: 2016
The Antibiotics Resistance Challenge: Find Out-Licensing Opportunities and More on Biotechgate
Antibiotic resistance has become a significant problem in the global healthcare market. Over-prescribing and misuse, along with the lack of new drug development, means that both governments and the life science industry as a whole have begun to take steps to partner with or fund those companies researching infectious diseases; this is especially true for … Continue reading The Antibiotics Resistance Challenge: Find Out-Licensing Opportunities and More on Biotechgate
Spanish Life Sciences Trend Analysis 2016
The second half of 2015 was hugely successful in terms of private investment in Spanish biotech companies, both in Catalonia and throughout Spain as a whole. Companies raised USD 86.6m in H2 of last year, compared to USD 5.6m in the six months previously. You can download our full trend analysis below. Spanish LS Trend … Continue reading Spanish Life Sciences Trend Analysis 2016
Discover How Biotechgate Can Help You In-License New Products
One of the key elements of the Biotechgate database is the Licensing Opportunities search feature. This section of Biotechgate gives the user access to over 4,000 licensing opportunities. The user-friendly search format enables you as the user to quickly and precisely identify the most relevant products. The search format has several filters which allow the … Continue reading Discover How Biotechgate Can Help You In-License New Products
Dutch Life Sciences Trend Analysis 2016
While the first semester of 2015 was a quiet period, the second half of last year saw private Dutch biotech companies raise over USD 115m worth of funding in six rounds. Indeed it proved to be the largest financing period since the first semester of 2012. Dutch LS Trend Analysis 2016 Looking for your … Continue reading Dutch Life Sciences Trend Analysis 2016
Biotechgate strengthens its UK network – Welcome OBN and Life Sciences Hub Wales
Zurich, March 2016: Venture Valuation’s Biotechgate enters into a partnership with OBN and Life Sciences Hub Wales to create two new directories for biotechnology in the UK; thus enhancing our network of biotech and life science … Continue reading Biotechgate strengthens its UK network – Welcome OBN and Life Sciences Hub Wales
Biotechgate enters collaboration with Nasdaq GlobeNewswire
Biotechgate, owned by Venture Valuation has partnered with Nasdaq GlobeNewswire to distribute Nasdaq’s GlobeNewswire press releases on Biotechgate and all its related country portals. Through the collaboration, Biotechgate will provide Nasdaq GlobeNewswire with an additional worldwide and focused publication channel. Biotechgate will publish the Biotech and life science related news on its website www.biotechgate.com and … Continue reading Biotechgate enters collaboration with Nasdaq GlobeNewswire
UK Life Sciences Trend Analysis 2015
2015 was a good year for Biotechnology Financing in the UK. Indeed the two semesters were stable at around 900m USD each. That is 10 times the amount of 2010 and over twice that of 2014. UK LS Trend Analysis 2015 Looking for your next Biotech or Medtech partner? Use Biotechgate to identify new … Continue reading UK Life Sciences Trend Analysis 2015